4//SEC Filing
Hernday Natasha 4
Accession 0001626199-23-000018
CIK 0001626199other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:58 PM ET
Size
5.7 KB
Accession
0001626199-23-000018
Insider Transaction Report
Form 4
Hernday Natasha
Director
Transactions
- Award
Stock Option (Right to buy)
2023-01-03+10,000→ 10,000 totalExercise: $7.43Exp: 2033-01-02→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
- [F2]1/12th of the shares subject to the option become vested and exercisable on February 3, 2023 and 1/12 of the shares subject to the option shall vest monthly thereafter.
Documents
Issuer
ALPINE IMMUNE SCIENCES, INC.
CIK 0001626199
Entity typeother
Related Parties
1- filerCIK 0001780547
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:58 PM ET
- Size
- 5.7 KB